ArticleJournal for immunotherapy of cancer2022

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.

Camille Le Gall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.